
About Mukka Proteins Limited
Data last updated:
Mukka Proteins Limited is a public limited company based in Mangalore, Karnataka, India. It operates in the fishing segment of the agriculture sector. It was incorporated on 04 November 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN L10207KA2010PLC055771. Its GSTIN is 29AAGCM8310E1ZJ (Karnataka). The company holds 6 GST registrations, of which 4 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 544135 and NSE: MUKKA.
The company has an authorised share capital of ₹40 Cr and a paid-up capital of ₹30 Cr. It was formerly known as Mukka Sea Food Industries Private Limited and Mukka Sea Food Industries Limited. It is led by directors including Kalandan Mohammed Haris (Managing Director) and Kalandan Mohammed Althaf (Whole-Time Director).
Its last annual general meeting (AGM) was held on 10 September 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mangalore, Karnataka.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹1,449.45 Cr, a growth of 44% compared to the previous year. For the same year it recorded a net profit of ₹51.96 Cr (net margin 3.6%) and EBITDA of ₹114.57 Cr (EBITDA margin 7.9%). The net worth stands at ₹499.09 Cr (up 13.2% YoY). Total assets are valued at ₹1,310.59 Cr (up 43.7% YoY).
The company has about 182 employees on its provident fund (EPFO) records. Its group structure includes 3 subsidiaries.
The company is associated with 1 brand: Mukka Proteins. As per MCA filings, the company has open charges of ₹590.64 Cr and satisfied charges of ₹217.5 Cr on record. Court records list 27 cases involving the company, including 12 filed by the company and 15 filed against it; 9 cases are pending. The company has 24 deals on record (18 secondary share transfers, 5 market trades, 1 ipo); the latest was in July 2024. The company has 4 MSME Form 1 returns on record between 2022 and 2024, listing 57 overdue payments to 16 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mukkaproteins.com.
Company details
Name history
Mukka Proteins has undergone 2 name changes throughout its history. The company was previously known as Mukka Sea Food Industries Private Limited, and Mukka Sea Food Industries Limited. The current legal name is Mukka Proteins Limited.
| Company Name | Status |
|---|---|
| Mukka Proteins Limited | Current |
| Mukka Sea Food Industries Private Limited | Previous |
| Mukka Sea Food Industries Limited | Previous |
CIN history
Mukka Proteins has 4 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L10207KA2010PLC055771, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L10207KA2010PLC055771 | Current |
| U05004KA2010PLC055771 | Previous |
| U05004KA2010PTC055771 | Previous |
| L05004KA2010PLC055771 | Previous |
| L10809KA2010PLC055771 | Previous |
Contact details
Mukka Proteins Limited's registered office is in Mangaluru, Karnataka. Its website is mukkaproteins.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressMukka Corporate House Door No. 18 – 2 – 16/4 First Cross Ng Road, Attavara, Mangalore, Karnataka, India – 575001
- IndustryAgriculture, Fishing
To see the full contact details of Mukka Proteins Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Mukka Proteins operates one associated brand: Mukka Proteins. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Fish oil, meal, and related marine products are distributed. | mukkaproteins.com |
Business activity
The main business activity of Mukka Proteins is manufacturing. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities |
To see the full business activity and turnover split of Mukka Proteins Limited, buy the company report.
Financials of Mukka Proteins Limited
FY 2025-26 filings availableMukka Proteins Limited reported revenue of ₹1,449.45 Cr (up 44% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,449 | 1,006 | 1,380 | 1,177 | 770 | 604 | 549 |
| Revenue growth | +44.0% | -27.1% | +17.2% | +52.8% | +27.6% | +9.9% | - |
| EBITDA | 115 | 94.89 | 105 | 86.16 | 46.77 | 21.87 | 23.80 |
| EBITDA margin | +7.9% | +9.4% | +7.6% | +7.3% | +6.1% | +3.6% | +4.3% |
| Profit before tax | 75.13 | 60.27 | 87.46 | 65.93 | 35.97 | 15.45 | 19.74 |
| Net profit | 51.96 | 46.43 | 69.73 | 44.25 | 23.39 | 5.67 | 11.31 |
| Net profit margin | +3.6% | +4.6% | +5.1% | +3.8% | +3.0% | +0.9% | +2.1% |
| EPS (₹) | 1.74 | 1.55 | 2.34 | 2.00 | 1.10 | 163.20 | 239.56 |
| Balance sheet | |||||||
| Total assets | 1,311 | 912 | 776 | 420 | 280 | 230 | 201 |
| Net worth | 499 | 441 | 396 | 148 | 98.37 | 66.52 | 56.55 |
| Total debt | 779 | 453 | 365 | 262 | 175 | 159 | 142 |
| Cash & bank | 60.43 | 42.29 | 127 | 29.02 | 13.89 | 4.19 | 1.65 |
| Net working capital | 978 | 764 | 654 | 312 | 177 | 135 | 116 |
| Cash flow | |||||||
| Cash from operations | (111) | (112) | (150) | (56.33) | 4.87 | 1.79 | (25.07) |
| Cash from investing | (146) | (34.99) | (47.59) | (3.32) | (11.48) | (13.61) | (27.97) |
| Cash from financing | 267 | 55.55 | 266 | 74.67 | 14.99 | 13.48 | 53.79 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 490 | 381 | 654 | 245 | 171 | 382 | 303 | 149 |
| Revenue growth (YoY) | +186.7% | -0.3% | +115.6% | +63.9% | -1.0% | - | - | - |
| Other income | 1.59 | 15.32 | 7.77 | 6.00 | 2.56 | 4.15 | 6.32 | 3.97 |
| EBITDA | 47.03 | 33.87 | 45.44 | 20.28 | 14.10 | 29.08 | 41.35 | 9.57 |
| EBITDA margin | +9.9% | +9.2% | +7.2% | +8.6% | +8.6% | +7.8% | +14.0% | +6.6% |
| Depreciation | 4.80 | 5.13 | 4.03 | 4.18 | 3.26 | 2.82 | 3.80 | 3.76 |
| Interest | 16.45 | 15.17 | 14.56 | 12.82 | 11.04 | 10.32 | 10.91 | 8.72 |
| Profit before tax | 27.37 | 28.89 | 34.62 | 9.28 | 2.36 | 20.09 | 32.96 | 1.06 |
| Tax | 8.74 | 7.53 | 7.37 | 2.39 | 0.77 | 6.10 | 6.17 | (0.42) |
| Net profit | 18.63 | 21.36 | 27.25 | 6.89 | 1.59 | 13.99 | 26.79 | 1.48 |
| EPS (₹) | 0.63 | 0.69 | 0.79 | 0.20 | 0.05 | 0.45 | 0.88 | 0.07 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,229 | 887 | 1,269 | 1,066 | 693 | 536 | 546 |
| Revenue growth | +38.6% | -30.1% | +19.0% | +53.9% | +29.2% | -1.7% | - |
| EBITDA | 86.38 | 76.11 | 81.38 | 65.66 | 32.53 | 6.87 | 20.08 |
| EBITDA margin | +7.0% | +8.6% | +6.4% | +6.2% | +4.7% | +1.3% | +3.7% |
| Profit before tax | 58.80 | 52.57 | 71.65 | 55.08 | 28.20 | 6.07 | 18.83 |
| Net profit | 42.35 | 41.67 | 62.60 | 37.99 | 18.78 | 2.60 | 10.66 |
| Net profit margin | +3.5% | +4.7% | +4.9% | +3.6% | +2.7% | +0.5% | +2.0% |
| EPS (₹) | 1.41 | 1.39 | 2.09 | 1.79 | 0.90 | 83.84 | 233.41 |
| Balance sheet | |||||||
| Total assets | 1,132 | 824 | 699 | 361 | 246 | 190 | 171 |
| Net worth | 447 | 404 | 365 | 122 | 82.29 | 62.86 | 57.53 |
| Total debt | 682 | 418 | 332 | 238 | 162 | 126 | 112 |
| Cash & bank | 48.06 | 39.21 | 124 | 23.03 | 8.10 | 2.08 | 0.89 |
| Net working capital | 925 | 709 | 600 | 286 | 177 | 130 | 118 |
| Cash flow | |||||||
| Cash from operations | (161) | (132) | (141) | (46.96) | (15.30) | (2.33) | (24.06) |
| Cash from investing | (42.73) | (18.02) | (46.25) | 0.71 | (7.25) | (5.41) | 1.81 |
| Cash from financing | 205 | 59.65 | 258 | 61.12 | 27.25 | 8.05 | 22.64 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 406 | 313 | 558 | 222 | 136 | 325 | 287 | 126 |
| Revenue growth (YoY) | +198.9% | -3.8% | +94.6% | +76.3% | -8.5% | - | - | - |
| Other income | 2.30 | 13.79 | 7.17 | 5.67 | 3.32 | 4.06 | 6.54 | 2.92 |
| Total expenses | 364 | 284 | 526 | 209 | 126 | 302 | 250 | 118 |
| EBITDA | 41.84 | 29.12 | 32.65 | 13.72 | 10.18 | 23.27 | 36.66 | 8.25 |
| EBITDA margin | +10.7% | +9.7% | +6.1% | +6.4% | +7.8% | +7.4% | +13.1% | +6.8% |
| Depreciation | 1.97 | 2.56 | 1.53 | 1.50 | 1.36 | 1.36 | 1.38 | 1.59 |
| Interest | 14.67 | 13.74 | 13.73 | 12.08 | 10.35 | 8.91 | 10.12 | 7.86 |
| Profit before tax | 27.50 | 26.61 | 24.56 | 5.81 | 1.79 | 17.06 | 31.70 | 1.72 |
| Tax | 8.09 | 7.70 | 5.81 | 2.20 | 0.66 | 3.97 | 6.59 | (0.47) |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 490 | 381 | 654 | 245 | 171 | 382 | 303 | 149 |
| Revenue growth (YoY) | +186.7% | -0.3% | +115.6% | +63.9% | -1.0% | - | - | - |
| Other income | 1.59 | 15.32 | 7.77 | 6.00 | 2.56 | 4.15 | 6.32 | 3.97 |
| EBITDA | 47.03 | 33.87 | 45.44 | 20.28 | 14.10 | 29.08 | 41.35 | 9.57 |
| EBITDA margin | +9.9% | +9.2% | +7.2% | +8.6% | +8.6% | +7.8% | +14.0% | +6.6% |
| Depreciation | 4.80 | 5.13 | 4.03 | 4.18 | 3.26 | 2.82 | 3.80 | 3.76 |
| Interest | 16.45 | 15.17 | 14.56 | 12.82 | 11.04 | 10.32 | 10.91 | 8.72 |
| Profit before tax | 27.37 | 28.89 | 34.62 | 9.28 | 2.36 | 20.09 | 32.96 | 1.06 |
| Tax | 8.74 | 7.53 | 7.37 | 2.39 | 0.77 | 6.10 | 6.17 | (0.42) |
| Net profit | 18.63 | 21.36 | 27.25 | 6.89 | 1.59 | 13.99 | 26.79 | 1.48 |
| EPS (₹) | 0.63 | 0.69 | 0.79 | 0.20 | 0.05 | 0.45 | 0.88 | 0.07 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,449 | 1,006 | 1,380 | 1,177 | 770 | 604 | 549 |
| Revenue growth | +44.0% | -27.1% | +17.2% | +52.8% | +27.6% | +9.9% | - |
| Other income | 30.75 | 16.18 | 19.42 | 8.14 | 7.46 | 9.94 | 7.84 |
| Total expenses | 1,335 | 912 | 1,274 | 1,091 | 724 | 582 | 525 |
| Employee cost | 40.78 | 32.30 | 29.33 | 24.66 | 19.36 | 14.97 | 8.31 |
| EBITDA | 115 | 94.89 | 105 | 86.16 | 46.77 | 21.87 | 23.80 |
| EBITDA margin | +7.9% | +9.4% | +7.6% | +7.3% | +6.1% | +3.6% | +4.3% |
| Depreciation | 16.59 | 13.55 | 12.34 | 11.89 | 8.58 | 8.34 | 4.69 |
| Interest | 53.60 | 37.25 | 25.10 | 16.48 | 9.68 | 8.02 | 7.21 |
| Profit before tax | 75.13 | 60.27 | 87.46 | 65.93 | 35.97 | 15.45 | 19.74 |
| Tax | 18.06 | 12.17 | 13.15 | 18.42 | 10.16 | 4.45 | 6.15 |
| Net profit | 51.96 | 46.43 | 69.73 | 44.25 | 23.39 | 5.67 | 11.31 |
| Net profit margin | +3.6% | +4.6% | +5.1% | +3.8% | +3.0% | +0.9% | +2.1% |
| EPS (₹) | 1.74 | 1.55 | 2.34 | 2.00 | 1.10 | 163.20 | 239.56 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 30.00 | 30.00 | 30.00 | 22.00 | 22.00 | 5.50 | 5.50 |
| Reserves & surplus | 469 | 411 | 366 | 126 | 76.37 | 61.02 | 51.05 |
| Shareholders' funds (net worth) | 499 | 441 | 396 | 148 | 98.37 | 66.52 | 56.55 |
| Minority interest | 29.69 | 15.80 | 12.22 | 8.04 | 4.71 | 3.40 | 1.20 |
| Secured loans | 587 | 342 | 258 | 158 | 134 | 144 | 126 |
| Unsecured loans | 192 | 111 | 108 | 104 | 40.74 | 15.04 | 15.68 |
| Total debt | 779 | 453 | 365 | 262 | 175 | 159 | 142 |
| Total liabilities | 1,311 | 912 | 776 | 420 | 280 | 230 | 201 |
| Assets | |||||||
| Gross block | 299 | 167 | 144 | 132 | 119 | 106 | 97.45 |
| Net block | 194 | 93.93 | 84.88 | 84.77 | 82.65 | 79.01 | 78.39 |
| Capital work in progress | 30.64 | 8.56 | 0.00 | 0.00 | 0.00 | 4.03 | 2.19 |
| Investments | 55.84 | 36.66 | 31.10 | 21.34 | 20.53 | 11.75 | 3.50 |
| Inventories | 857 | 564 | 423 | 230 | 165 | 150 | 115 |
| Sundry debtors | 182 | 200 | 185 | 113 | 61.33 | 47.89 | 35.00 |
| Cash & bank balances | 60.43 | 42.29 | 127 | 29.02 | 13.89 | 4.19 | 1.65 |
| Loans & advances | 190 | 119 | 81.13 | 91.99 | 46.30 | 55.44 | 54.36 |
| Total current assets | 1,289 | 926 | 817 | 464 | 286 | 257 | 206 |
| Total current liabilities | 311 | 162 | 163 | 152 | 109 | 122 | 89.75 |
| Net working capital | 978 | 764 | 654 | 312 | 177 | 135 | 116 |
| Total assets | 1,311 | 912 | 776 | 420 | 280 | 230 | 201 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 3.08 | 94.44 | 26.55 | 11.54 | 3.15 | 1.49 | 0.91 |
| Net cash from operating activities | (111) | (112) | (150) | (56.33) | 4.87 | 1.79 | (25.07) |
| Net cash from investing activities | (146) | (34.99) | (47.59) | (3.32) | (11.48) | (13.61) | (27.97) |
| Net cash from financing activities | 267 | 55.55 | 266 | 74.67 | 14.99 | 13.48 | 53.79 |
| Net change in cash | 9.81 | (91.36) | 67.89 | 15.01 | 8.38 | 1.66 | 0.74 |
| Closing cash | 60.43 | 42.29 | 127 | 29.02 | 13.89 | 4.19 | 1.65 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +44.0% | -27.1% | +17.2% | +52.8% | +27.6% | +9.9% | - |
| EBITDA growth | +20.7% | -10.0% | +22.4% | +84.2% | +113.9% | -8.1% | - |
| PBT growth | +24.7% | -31.1% | +32.7% | +83.3% | +132.8% | -21.7% | +5.0% |
| Net income growth | +11.9% | -33.4% | +57.6% | +89.2% | +312.5% | -49.9% | - |
| Revenue CAGR (3Y) | +7.2% | +9.3% | +31.7% | +28.9% | +23.5% | - | - |
| EBITDA CAGR (3Y) | +10.0% | +26.6% | +69.0% | +53.6% | +35.1% | - | - |
| Profitability & leverage | |||||||
| Net income margin | +3.9% | +4.8% | +5.4% | +4.0% | +3.4% | +1.8% | +2.5% |
| Return on capital employed | +11.8% | +11.8% | +19.2% | +24.0% | +18.2% | +9.1% | +15.0% |
| Return on net worth | +12.2% | +11.5% | +27.3% | +38.6% | +31.3% | +12.5% | +23.3% |
| Debt / equity | 1.31 | 0.98 | 1.15 | 1.77 | 2.03 | 2.44 | 2.23 |
| Long-term debt / equity | 0.05 | 0.01 | 0.03 | 0.09 | 0.12 | 0.21 | 0.34 |
| Interest cover | 54.71 | 45.80 | 26.95 | 22.19 | 25.35 | 59.28 | 37.73 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 6.22 | 6.47 | 10.00 | 9.39 | 6.84 | 5.92 | 7.05 |
| Inventory turnover | 2.04 | 2.04 | 4.23 | 5.97 | 4.90 | 4.56 | 5.36 |
| Debtors turnover | 7.60 | 5.23 | 9.24 | 13.48 | 14.11 | 14.57 | 17.30 |
| EPS (₹) | 1.74 | 1.55 | 2.34 | 2.00 | 1.10 | 163.20 | 239.56 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 16.64 | 14.69 | 13.20 | 6.72 | 4.47 | 1,209.53 | 1,028.18 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 406 | 313 | 558 | 222 | 136 | 325 | 287 | 126 |
| Revenue growth (YoY) | +198.9% | -3.8% | +94.6% | +76.3% | -8.5% | - | - | - |
| Other income | 2.30 | 13.79 | 7.17 | 5.67 | 3.32 | 4.06 | 6.54 | 2.92 |
| Total expenses | 364 | 284 | 526 | 209 | 126 | 302 | 250 | 118 |
| EBITDA | 41.84 | 29.12 | 32.65 | 13.72 | 10.18 | 23.27 | 36.66 | 8.25 |
| EBITDA margin | +10.7% | +9.7% | +6.1% | +6.4% | +7.8% | +7.4% | +13.1% | +6.8% |
| Depreciation | 1.97 | 2.56 | 1.53 | 1.50 | 1.36 | 1.36 | 1.38 | 1.59 |
| Interest | 14.67 | 13.74 | 13.73 | 12.08 | 10.35 | 8.91 | 10.12 | 7.86 |
| Profit before tax | 27.50 | 26.61 | 24.56 | 5.81 | 1.79 | 17.06 | 31.70 | 1.72 |
| Tax | 8.09 | 7.70 | 5.81 | 2.20 | 0.66 | 3.97 | 6.59 | (0.47) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,229 | 887 | 1,269 | 1,066 | 693 | 536 | 546 |
| Revenue growth | +38.6% | -30.1% | +19.0% | +53.9% | +29.2% | -1.7% | - |
| Other income | 29.27 | 16.65 | 20.08 | 8.87 | 7.74 | 9.15 | 8.14 |
| Total expenses | 1,143 | 811 | 1,187 | 1,001 | 660 | 529 | 526 |
| Employee cost | 24.51 | 21.64 | 21.04 | 17.14 | 13.13 | 9.90 | 7.15 |
| EBITDA | 86.38 | 76.11 | 81.38 | 65.66 | 32.53 | 6.87 | 20.08 |
| EBITDA margin | +7.0% | +8.6% | +6.4% | +6.2% | +4.7% | +1.3% | +3.7% |
| Depreciation | 6.94 | 5.86 | 5.62 | 4.27 | 3.72 | 3.00 | 2.80 |
| Interest | 49.91 | 34.33 | 24.19 | 15.18 | 8.35 | 6.95 | 6.59 |
| Profit before tax | 58.80 | 52.57 | 71.65 | 55.08 | 28.20 | 6.07 | 18.83 |
| Tax | 16.37 | 10.90 | 8.89 | 15.68 | 8.38 | 1.44 | 5.98 |
| Net profit | 42.35 | 41.67 | 62.60 | 37.99 | 18.78 | 2.60 | 10.66 |
| Net profit margin | +3.5% | +4.7% | +4.9% | +3.6% | +2.7% | +0.5% | +2.0% |
| EPS (₹) | 1.41 | 1.39 | 2.09 | 1.79 | 0.90 | 83.84 | 233.41 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 30.00 | 30.00 | 30.00 | 22.00 | 22.00 | 5.50 | 5.50 |
| Reserves & surplus | 417 | 374 | 335 | 99.64 | 60.29 | 57.36 | 52.03 |
| Shareholders' funds (net worth) | 447 | 404 | 365 | 122 | 82.29 | 62.86 | 57.53 |
| Secured loans | 497 | 307 | 223 | 136 | 122 | 123 | 106 |
| Unsecured loans | 186 | 111 | 108 | 102 | 40.84 | 2.84 | 6.30 |
| Total debt | 682 | 418 | 332 | 238 | 162 | 126 | 112 |
| Total liabilities | 1,132 | 824 | 699 | 361 | 246 | 190 | 171 |
| Assets | |||||||
| Gross block | 127 | 91.88 | 86.70 | 73.98 | 68.33 | 64.02 | 57.58 |
| Net block | 88.32 | 59.49 | 59.76 | 52.42 | 49.69 | 49.01 | 45.50 |
| Capital work in progress | 0.54 | 3.80 | 0.00 | 0.00 | 0.00 | 0.00 | 1.22 |
| Investments | 71.03 | 43.80 | 34.38 | 23.63 | 20.67 | 11.53 | 6.68 |
| Inventories | 774 | 521 | 393 | 208 | 141 | 142 | 90.24 |
| Sundry debtors | 174 | 155 | 143 | 108 | 53.00 | 26.46 | 54.41 |
| Cash & bank balances | 48.06 | 39.21 | 124 | 23.03 | 8.10 | 2.08 | 0.89 |
| Loans & advances | 164 | 142 | 89.62 | 80.74 | 55.07 | 55.53 | 56.48 |
| Total current assets | 1,160 | 856 | 750 | 420 | 257 | 226 | 202 |
| Total current liabilities | 235 | 147 | 149 | 135 | 79.51 | 95.83 | 84.48 |
| Net working capital | 925 | 709 | 600 | 286 | 177 | 130 | 118 |
| Total assets | 1,132 | 824 | 699 | 361 | 246 | 190 | 171 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.44 | 91.18 | 20.62 | 5.75 | 1.04 | 0.73 | 0.51 |
| Net cash from operating activities | (161) | (132) | (141) | (46.96) | (15.30) | (2.33) | (24.06) |
| Net cash from investing activities | (42.73) | (18.02) | (46.25) | 0.71 | (7.25) | (5.41) | 1.81 |
| Net cash from financing activities | 205 | 59.65 | 258 | 61.12 | 27.25 | 8.05 | 22.64 |
| Net change in cash | 1.50 | (90.74) | 70.57 | 14.87 | 4.70 | 0.31 | 0.38 |
| Closing cash | 48.06 | 39.21 | 124 | 23.03 | 8.10 | 2.08 | 0.89 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +38.6% | -30.1% | +19.0% | +53.9% | +29.2% | -1.7% | - |
| EBITDA growth | +13.5% | -6.5% | +23.9% | +101.8% | +373.5% | -65.8% | - |
| PBT growth | +11.9% | -26.6% | +30.1% | +95.3% | +364.6% | -67.8% | -8.2% |
| Net income growth | +1.6% | -33.4% | +64.8% | +102.3% | +622.3% | -75.6% | - |
| Revenue CAGR (3Y) | +4.9% | +8.6% | +33.2% | +25.0% | +19.4% | - | - |
| EBITDA CAGR (3Y) | +9.6% | +32.8% | +128.0% | +48.4% | +16.9% | - | - |
| Profitability & leverage | |||||||
| Net income margin | +3.5% | +4.7% | +5.0% | +3.7% | +2.9% | +0.9% | +2.4% |
| Return on capital employed | +11.1% | +11.4% | +18.1% | +23.1% | +16.8% | +5.8% | +15.0% |
| Return on net worth | +10.0% | +10.8% | +25.8% | +38.7% | +27.3% | +4.3% | +20.7% |
| Debt / equity | 1.29 | 0.97 | 1.17 | 1.96 | 1.99 | 1.98 | 1.87 |
| Long-term debt / equity | 0.02 | 0.01 | 0.02 | 0.02 | 0.00 | 0.08 | 0.24 |
| Interest cover | 62.83 | 48.87 | 31.93 | 24.73 | 28.98 | 179.59 | 38.14 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 11.24 | 9.93 | 15.79 | 14.99 | 10.47 | 8.82 | 9.88 |
| Inventory turnover | 1.90 | 1.94 | 4.22 | 6.11 | 4.91 | 4.62 | 6.08 |
| Debtors turnover | 7.48 | 5.95 | 10.09 | 13.22 | 17.44 | 13.26 | 13.77 |
| EPS (₹) | 1.41 | 1.39 | 2.09 | 1.79 | 0.90 | 83.84 | 233.41 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 14.91 | 13.48 | 12.17 | 5.53 | 3.74 | 1,142.93 | 1,046.08 |
To see the full year-wise statements and ratios of Mukka Proteins Limited, buy the company report.
Board of directors of Mukka Proteins Limited
Mukka Proteins has 8 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kalandan Abdul Razak Also directs: Haris Marine Products Private Limited | Director | 22 Feb 2021 | 5 Years 8 Months | Current |
| Kalandan Mohammed Althaf Also directs: Haris Marine Products Private Limited, Shipwaves Online Limited, Ocean Proteins Private Limited and 3 more | Whole-Time Director | 04 Nov 2010 | 15 Years 11 Months | Current |
| Umaiyya Banu | Director | 04 Nov 2010 | 15 Years 11 Months | Current |
| Karkala Shankar Balachandra Rao Also directs: Shipwaves Online Limited | Director | 15 Jan 2022 | 4 Years 9 Months | Current |
| Hamad Bava Also directs: Shipwaves Online Limited | Director | 15 Jan 2022 | 4 Years 9 Months | Current |
| Narendra Surendra Kamath Also directs: Shipwaves Online Limited | Director | 15 Jan 2022 | 4 Years 9 Months | Current |
Auditor
Mukka Proteins Limited is audited by Shah & Taparia for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Shah & Taparia | FY 2025 | 109463W |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 73.30%, foreign institutional investors hold 1.70%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 25.00%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 73.30% | 73.30% | 73.30% | 73.30% |
| Public | 26.70% | 26.70% | 26.70% | 26.70% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Jul 2026 | 101357283 | Axis Bank Limited | ₹11.64 Cr | Open | |
| 20 Jun 2026 | 101356855 | Hdfc Bank Limited | ₹54.99 Cr | Open | |
| 14 Nov 2025 | 101182297 | Others | ₹50 Cr | Open | |
| 25 Aug 2025 | 101155897 | Axis Bank Limited | ₹15 Cr | Open | |
| 31 Jul 2025 | 101135240 | State Bank of India | ₹139 Cr | Open |
To see the full charge records of Mukka Proteins Limited, buy the company report.
Total charge records: 21 View all charges
Deals & funding
Mukka Proteins Limited has 24 deals on record (18 secondary share transfers, 5 market trades, 1 ipo); the latest was in July 2024.
Deals on record (5 of 24)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2024 | Market trade | ₹73.19 Cr | Buyer: Hrti Private Limited , Graviton Research Capital LLP , NK Securities Research Private Limited Seller: Hrti Private Limited , Graviton Research Capital LLP , NK Securities Research Private Limited |
| Jul 2024 | Market trade | ₹27.75 Cr | Buyer: Graviton Research Capital LLP , Hrti Private Limited , Qe Securities LLP Seller: Graviton Research Capital LLP , Hrti Private Limited , Qe Securities LLP |
| Jul 2024 | Market trade | ₹14.14 Cr | Buyer: Graviton Research Capital LLP , Hrti Private Limited Seller: Hrti Private Limited , Graviton Research Capital LLP |
| Mar 2024 | Market trade | ₹6.48 Cr | Seller: Multiplier Share and Stock Advisors Private Limited |
| Mar 2024 | Market trade | ₹15.65 Cr | Buyer: Multiplier Share and Stock Advisors Private Limited |
To see the full deal history of Mukka Proteins Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Mukka Proteins Limited has 27 court cases on record: 12 filed by Mukka Proteins, 15 filed against it. 9 cases are pending and 18 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 15 | 6 | 4 |
| District courts | 12 | 9 | 5 |
Cases on record (5 of 27)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, DAKSHINA KANNADA, Karnataka | Civil suit | Filed by the company against an individual | Pending |
| High Court, KARNATAKA | Writ petition | Filed by the company against The Chairman Marine Products Export Development Authority and 1 other | Pending |
| District court, DAKSHINA KANNADA, Karnataka | Criminal complaint | Filed against the company by an individual | Pending |
| District court, DAKSHINA KANNADA, Karnataka | Civil suit | Filed against the company | Pending |
| District court, UDUPI, Karnataka | Court case (ECA) | Filed against the company by an individual | Pending |
To see the full case history of Mukka Proteins Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Mukka Proteins Limited was last rated by Icra on 05 Oct 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 05 Oct 2021 |
To see the full credit ratings and regulatory alerts of Mukka Proteins Limited, buy the company report.
MSME payment delays
Mukka Proteins Limited has 4 MSME Form 1 returns on record between 2022 and 2024, listing 57 overdue payments to 16 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 16)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| H K A Bawa and Sons | |||
| Bismi Fisheries Private Limited | |||
| Kwality Fisheries | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Mukka Proteins Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Mukka Proteins has 3 subsidiary companies and 1 associated company. This group structure data is as of FY 2025. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Proteins LLC Haris Marine Products Private Limited | U05001KA2019PTC129205 | |
| Atlantic Marine Products Private Limited | U05150GJ2019PTC110796 | |
| Ento Proteins Private Limited | U15209KA2021PTC145044 |
To see the full group structure of Mukka Proteins Limited, buy the company report.
Employees & EPFO
Mukka Proteins Limited has a workforce of 182 employees on its EPFO records as of Oct 11, 2025, across 1 active EPFO establishment.
GST
Mukka Proteins has 6 GST registrations: 4 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAGCM8310E1ZJ | Karnataka | Active | 01 Jul 2017 |
| 29AAGCM8310E2ZI | Karnataka | Active | 14 Jul 2025 |
| 24AAGCM8310E1ZT | Gujarat | Active | 25 Jun 2018 |
| 21AAGCM8310E1ZZ | Odisha | Active | 02 Jul 2025 |
To see the full GST registrations and return filing status of Mukka Proteins Limited, buy the company report.
Recent activity
Mukka Proteins Limited has 9 board changes on record since 2010: 8 appointments and 1 cessation. The latest: Hamad Bava was appointed as Director on 15 Jan 2022.
43 earlier events are in the company report.
News
Frequently asked questions
Mukka Proteins is an active public limited company based in Mangalore, Karnataka, India. The company works in fishing, within the agriculture industry. It was incorporated on 04 November 2010 (16+ years old) and is registered under CIN L10207KA2010PLC055771. Listed on BSE: 544135 and NSE: MUKKA.
Mukka Proteins reported revenue of ₹1,449.45 Cr for FY 2025-26 (up 44% YoY) based on consolidated financials.
Mukka Proteins has 8 current directors:
- Kalandan Mohammed Haris - Managing Director
- Kalandan Mohammed Althaf - Whole-Time Director
- Kalandan Mohammad Arif - Whole-Time Director
- Kalandan Abdul Razak - Director
- Umaiyya Banu - Director
- Karkala Shankar Balachandra Rao - Director
- Hamad Bava - Director
- Narendra Surendra Kamath - Director
The latest financial statements of Mukka Proteins on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 10 September 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Mukka Proteins is 29AAGCM8310E1ZJ, registered in Karnataka. The company has 6 GST registrations in all, of which 4 are active and 2 are cancelled or inactive. Other active GSTINs include 29AAGCM8310E2ZI (Karnataka), 24AAGCM8310E1ZT (Gujarat), 21AAGCM8310E1ZZ (Odisha).
The CIN (Corporate Identification Number) of Mukka Proteins is L10207KA2010PLC055771. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Mukka Proteins is a listed company as per MCA records. Its shares are listed on both BSE (code: 544135) and NSE (symbol: MUKKA).
Mukka Proteins has 27 court cases on record: 12 filed by the company and 15 filed against it. 9 are pending. Most are in the high courts.
Mukka Proteins was incorporated on 04 November 2010, making it 16+ years old. It is registered with the Registrar of Companies, Bangalore.
Mukka Proteins has 24 deals on record (18 secondary share transfers, 5 market trades, 1 ipo); the latest was in July 2024.
Hamad Bava was appointed as Director on 15 Jan 2022. Karkala Shankar Balachandra Rao was appointed as Director on 15 Jan 2022. Narendra Surendra Kamath was appointed as Director on 15 Jan 2022. Mukka Proteins has 9 board changes on record in total.